DBV Technologies S.A. (DBVT:NASDAQ) closed at $11.02 on November 13, 2026, down 3.63% on the day. The stock trades 57.9% below its 52-week high of $26.19 and 27.6% above its 52-week low of $8.63. Over the past year, it lost 16.8%. DBV Technologies S.A. is part of the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)).
In 252 trading sessions since November 13, 2025, DBVT closed higher on 109 days (43%). Its best day was December 17, 2025 (+25.42%) and its worst was March 11, 2026 (-12.02%). The stock moved 10% or more in a single session 10 times. It opened at least 5% above the previous day's high 3 times.
DBV Technologies S.A. is engaged in the research, development, and marketing of products for the diagnosis and treatment of allergies, primarily food allergies in young children. The company provides Diallertest, a non-invasive patch allergy diagnostic for infants, children, or adults for the diagnosis of allergy in cow milk, wheat, and soybean. Its products include Viaskin Peanut, an immunotherapy product for the treatment of patients with peanut allergies; Viaskin Milk, for the treatment of CMPA and eosinophilic esophagitis, as well as food polyallergies; and Viaskin House Dust Mite, a mite desensitization product for the treatment of mite allergy. The company was founded in 2002 and is based in Bagneux, France.
Find more stocks like DBVT with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.